Translating Discoveries to the Marketplace
Edited by Phillip H. Phan
Chapter 3: When do biotechnology ventures pursue international R & D alliances?
Hakan Ener and Ha Hoang
Technology ventures often develop products domestically and license them out to large companies for worldwide commercialization. However, international R & D alliances provide an alternative – potentially more rewarding – path to foreign markets. We hypothesize that this path is especially attractive for firms underperforming in terms of product development success relative to aspirations. Our regression analyses in a sample of US-based biotechnology ventures reveal that low performance leads ventures to partner internationally while high-performing ventures refrain from international research and development (R & D) alliances. Thus, pursuing a novel product commercialization.
You are not authenticated to view the full text of this chapter or article.
Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.
Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.
Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.